STOCK TITAN

JANUS LIVING INC SEC Filings

JAN NYSE

Welcome to our dedicated page for JANUS LIVING SEC filings (Ticker: JAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Janus Living, Inc. filings document the public-company disclosures of a Maryland senior housing REIT with Class A-1 common stock listed on the New York Stock Exchange. Its SEC records include Form 8-K reports on operating and financial results, Regulation FD materials, non-GAAP reconciliations, and material-event disclosures tied to its REIT operations.

Janus Living’s filing record also covers its registered Form S-11 offering, capital-structure matters, shareholder voting categories, governance disclosures, and material agreements, including financing arrangements that support liquidity and external growth. These filings provide formal records of the company’s securities, public offering history, reporting status, and recurring REIT financial disclosure subjects.

Rhea-AI Summary

Jane Street Group and affiliates report beneficial ownership of ALT5 Sigma Corp common stock totaling 10,061,351 shares, representing 8.2% of the class. The ownership reported is held with shared voting and dispositive power rather than sole control. The filing identifies four related reporting persons—Jane Street Group, LLC; Jane Street Global Trading, LLC; Jane Street Capital, LLC; and Jane Street Options, LLC—with the largest holdings attributed to the Group and Global Trading affiliate. The statement clarifies these positions are not intended to change or influence control of the issuer and lists the issuer's principal executive office.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Schedule 13G filed jointly by ExodusPoint entities and two individuals reports beneficial ownership of shares of ALT5 Sigma Corp common stock. As of August 11, 2025 the Reporting Persons were deemed to beneficially own 6,200,000 shares (about 5.05% of the class) held by ExodusPoint Partners Master Fund, LP; as of the filing date they report they may be deemed to own 5,856,700 shares (about 4.75%). The reporting group has no sole voting or dispositive power and reports shared voting and dispositive power over 5,856,700 shares. The filing includes a Joint Filing Agreement as Exhibit 99.1 and certifications that the holdings are not for purposes of changing control.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

JanOne Inc. (JAN) discloses that certain private placement securities (the "PIPE Securities" and Placement Agent Warrant Shares) were issued relying on Section 4(a)(2) and/or Regulation D exemptions and therefore were not registered under the Securities Act or state securities laws. Under a Registration Rights Agreement the company must file a registration statement to permit resale of the PIPE Securities within 15 days of the private placement closing. The company also describes a stockholder approval process for an Amendment and Exchange Cap, with the board recommending approval and an obligation to hold repeat meetings every 90 days until approval is obtained.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Point72 reports a 4.0% common-stock holding in ALT5 Sigma Corp. The filing lists Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen as joint filers reporting shared voting and dispositive power over 4,872,756 shares as of the close of business on August 15, 2025. The filers state they directly own no shares and that the shares are held by an investment fund managed by Point72 Asset Management. The filing includes a joint filing agreement and a certification that the stake was not acquired to influence control.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Virland A. Johnson, identified as the issuer's Chief Financial Officer, reported transactions dated 05/30/2025 under the issuer listed as ALT5 Sigma Corp (ALTS). On that date he received 25,000 common shares that vested as Restricted Stock Units under the company's 2024 Equity Incentive Plan at a reported per-share amount of $0.01, leaving him with 38,000 shares beneficially owned after the transaction. He also acquired 125,000 warrants with a conversion/exercise price of $9.31, exercisable on 05/30/2025 and expiring on 05/30/2030, representing the right to purchase 125,000 additional common shares. The Form 4 notes the RSUs vested on the transaction date and lists the holdings as direct beneficial ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

ALT5 Sigma Corporation (formerly JanOne Inc., ticker changed to ALTS) reported a sharp increase in fintech revenue alongside larger consolidated losses for the first half of 2025. For the 26 weeks ended June 28, 2025 revenue rose to $11.892 million from $2.169 million a year earlier, and cash and cash equivalents increased to $9.56 million from $7.177 million, reflecting operational receipts and financing activity.

Despite top-line growth, the company recorded a net loss of $11.976 million for the 26 weeks ended June 28, 2025 versus a $1.555 million loss in the prior-year period. Large other losses including a $(3.177) million realized amount on exchange transactions, increased intangible amortization and acquisition-related costs contributed to the wider loss. The company completed two fintech-focused acquisitions: ALT5 Subsidiary (May 2024) and Mswipe (May 9, 2025), with Mswipe purchase consideration fair-valued at $14.2 million and preliminary goodwill of $6.378 million. Digital assets receivable and payable remain material on the balance sheet at roughly $14.4 million and $23.6 million, respectively, and long-term notes payable increased to $21.551 million. The biotechnology operations (Alyea) are presented as discontinued operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Summary

Alt5 Sigma Corporation filed an 8-K noting that incoming board observer Zak Folkman and incoming board chairman Zach Witkolf will appear on CNBC’s “Squawk Box” on August 12, 2025, beginning as early as 7:45 AM EST. During the segment, they may discuss the company’s treasury strategy, including a focus on acquiring WLFI tokens and incorporating USD1 into Alt5’s broader financial ecosystem. They may also describe how Alt5 aims to position itself at the forefront of institutional-grade cryptocurrency payment solutions, offering services that bridge crypto and everyday financial use, and their expectations for integrating USD1 to enhance its payment services suite.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

ALT5 Sigma Corporation is offering 100,000,000 shares of common stock at $7.50 per share in a registered direct offering, generating gross proceeds of $750,000,000. The company agreed to pay placement agent fees equal to 3% (about $22,500,000) and to issue placement agent warrants equal to 3% of placement agent securities, exercisable at $8.25. Net proceeds are expected to be approximately $726,900,000. A concurrent private placement will issue 1,000,000 shares and pre-funded warrants to purchase up to 99,000,000 shares in exchange for $WLFI tokens; those tokens were contributed by the Lead Investor and were priced to the company at $0.20 per token.

The company intends to use $10,000,000 of net proceeds to settle litigation, pay debt and fund operations, and allocate the balance to acquire $WLFI tokens and establish a cryptocurrency treasury. After the offering, the company reports 121,609,376 shares outstanding. The prospectus highlights significant risks tied to the $WLFI strategy, including concentration, limited transferability and liquidity of $WLFI, regulatory and custody risks, potential Investment Company Act implications, and governance conflicts related to WLFI-affiliated parties.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

ALT5 Sigma Corporation (Nasdaq: ALTS) filed a prospectus supplement describing an at-the-market program to sell up to $1.0 billion of common stock through A.G.P./Alliance Global Partners with commissions of 2.5% on the first $500 million and 2.0% thereafter. The supplement discloses a concurrent Registered Direct Offering of 100,000,000 shares at $7.50 per share (expected gross proceeds $750 million) and a Private Placement under which the Company received $750 million of $WLFI tokens from the Lead Investor and issued 1,000,000 shares plus pre-funded warrants exercisable for up to 99,000,000 shares.

The company had 21,609,376 shares outstanding prior to the offerings and reported a last Nasdaq sale price of $8.97 on August 8, 2025. The supplement highlights material dilution metrics (historical net tangible book value of $(23.1M) or $(1.07) per share; pro forma as adjusted to $8.21 per share after a hypothetical $1.0B offering) and extensive risk disclosures tied to the planned $WLFI treasury strategy, including token non-transferability, concentration risk, custody and cybersecurity risks, regulatory uncertainty, and possible implications under the Investment Company Act.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

On August 11, 2025, ALT5 Sigma Corporation announced concurrent capital transactions that are expected to materially change its balance sheet and governance. The Company agreed to a registered direct offering to issue 100,000,000 shares at $7.50 per share (expected gross proceeds $750 million) and a concurrent private placement in which it received $750 million of $WLFI tokens from the Lead Investor in exchange for 1,000,000 shares at $7.50 and pre-funded warrants to purchase up to 99,000,000 additional shares.

The Company said it will use up to $10.0 million of net proceeds to settle litigation, pay debt and fund operations, with the remainder to purchase WLFI tokens and establish a cryptocurrency treasury. ALT5 also entered an ATM sales agreement to sell up to $1.0 billion of Common Stock, disclosed preliminary Q2 estimates (13-week revenue $6.0–6.5M; 26-week revenue $11.5–12.5M; cash ~ $9.5M; total assets ~$94–95M; current liabilities $58–59M) and announced board and management appointments, including Zachary Witkoff and Eric Trump.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many JANUS LIVING (JAN) SEC filings are available on StockTitan?

StockTitan tracks 45 SEC filings for JANUS LIVING (JAN), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for JANUS LIVING (JAN)?

The most recent SEC filing for JANUS LIVING (JAN) was filed on August 19, 2025.